An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding
Viruses · 2023
DOI: 10.3390/v15122289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Haiyan Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: University Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), 38000 Grenoble, France. Hauptthemen laut MEDLINE: HIV-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, ANR, Grenoble Instruct-ERIC center.
Abstract (Originalsprache)
HIV-1 budding as well as many other cellular processes require the Endosomal Sorting Complex Required for Transport (ESCRT) machinery. Understanding the architecture of the native ESCRT-III complex at HIV-1 budding sites is limited due to spatial resolution and transient ESCRT-III recruitment. Here, we developed a drug-inducible transient HIV-1 budding inhibitory tool to enhance the ESCRT-III lifetime at budding sites. We generated autocleavable CHMP2A, CHMP3, and CHMP4B fusion proteins with the hepatitis C virus NS3 protease. We characterized the CHMP-NS3 fusion proteins in the absence and presence of protease inhibitor Glecaprevir with regard to expression, stability, localization, and HIV-1 Gag VLP budding. Immunoblotting experiments revealed rapid and stable accumulation of CHMP-NS3 fusion proteins. Notably, upon drug administration, CHMP2A-NS3 and CHMP4B-NS3 fusion proteins substantially decrease VLP release while CHMP3-NS3 exerted no effect but synergized with CHMP2A-NS3. Localization studies demonstrated the relocalization of CHMP-NS3 fusion proteins to the plasma membrane, endosomes, and Gag VLP budding sites. Through the combined use of transmission electron microscopy and video-microscopy, we unveiled drug-dependent accumulation of CHMP2A-NS3 and CHMP4B-NS3, causing a delay in HIV-1 Gag-VLP release. Our findings provide novel insight into the functional consequences of inhibiting ESCRT-III during HIV-1 budding and establish new tools to decipher the role of ESCRT-III at HIV-1 budding sites and other ESCRT-catalyzed cellular processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), 38000 Grenoble, France.
- University Grenoble Alpes, CEA, CNRS, ISBG, 38000 Grenoble, France.
- University Grenoble Alpes, INSERM, IAB, 38000 Grenoble, France.
- Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
ORCID-Profile: Benoit Gallet, Mylène Pezet, Jean-Philippe Kleman, Winfried Weissenhorn
Förderung
- NIAID NIH HHS
- ANR
- Grenoble Instruct-ERIC center
- FRISBI
- GRAL
- Ecoles Universitaires de Recherche
- NIH
Zitieren
APA
Wang, H., Gallet, B., Moriscot, C., Pezet, M., Chatellard, C., Kleman, J. P., Göttlinger, H., Weissenhorn, W., & Boscheron, C. (2023). An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding. Viruses. https://doi.org/10.3390/v15122289
Vancouver
Wang H, Gallet B, Moriscot C, Pezet M, Chatellard C, Kleman JP, et al. An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding. Viruses. 2023. doi:10.3390/v15122289
BibTeX
@article{Wang2023,
author = {Wang, Haiyan and Gallet, Benoit and Moriscot, Christine and Pezet, Mylène and Chatellard, Christine and Kleman, Jean-Philippe and Göttlinger, Heinrich and Weissenhorn, Winfried and Boscheron, Cécile},
title = {An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15122289}
}
EUVIMED